Last update:
Oncology & Cancer news
Medical research
Precision breast cancer trial shows improved treatment by tumor subtype
Despite recent advances in the treatment of breast cancer, it remains the second leading cause of cancer death in the U.S. and worldwide. There is a continued need to improve treatment strategies and therapies that not only ...
50 minutes ago
0
0
Medical research
Researchers identify new therapeutic approach to preventing cancer from spreading to the brain
In a study published in the journal Cell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerability in metastatic brain cancer, which they say can be exploited with new drugs to prevent ...
27 minutes ago
0
0
Chemotherapy can be a challenging treatment—here's how to deal with some of the side-effects
Chemotherapy is a powerful cancer medication—but it can also be a very challenging treatment. It works by killing fast-growing cancer cells but kills healthy cells too, so it's important to know how to care for your body ...
20 minutes ago
0
0
Cellular power-up: Stem cells provide T cells a lifeline as cancer champions
In a pioneering study that bridges the gap between science fiction and reality, researchers have unveiled an innovative method to enhance T and CAR-T cells—our body's natural and engineered defenders against cancer—by ...
1 hour ago
0
10
Radon, even at levels below EPA guideline for mitigation, is linked to childhood leukemia
A study of more than 700 counties across multiple U.S. states found a link between childhood leukemia and levels of decaying radon gas, including those lower than the federal guideline for mitigation. The research is published ...
2 hours ago
0
48
Black, white cancer patients now benefit equally from cord blood therapy
Blood cancer patients of all races who receive cord blood transplants are now living longer.
2 hours ago
0
0
Researchers suggest rethinking 'cancer' label for early-stage prostate changes
A new paper in the Journal of the National Cancer Institute indicates that patients may benefit if doctors stop calling certain early-stage changes to the prostate "cancer" at all. The paper is titled "When is prostate cancer ...
11 hours ago
0
1
Analysis calculates $725M in economic potential from expanded cancer treatment access
A recent analysis, published in The Lancet Oncology, calculates that increasing access to [¹⁷⁷Lu]PSMA therapy for eligible patients could generate $725 million in economic potential. This impact is projected across nine ...
18 hours ago
0
61
MRI provides early warning system for glioblastoma growth
A new study shows the potential power of imaging paired with radiation to shape treatment for glioblastoma patients in real time.
17 hours ago
0
23
New drug combination shows promise for small cell lung cancer
Researchers at the Icahn School of Medicine at Mount Sinai have made a promising breakthrough in the treatment of small cell lung cancer (SCLC). Their study, published in Science Advances and titled "ATR Inhibition Activates ...
18 hours ago
0
1
Circular peptides in violets may aid in the fight against glioblastoma
Glioblastoma is one of the most serious brain diseases known. More than 45% of brain cancers are gliomas. Only half of glioblastoma patients respond to the FDA-approved chemotherapy temozolomide (TMZ). Even for those patients, ...
19 hours ago
0
10
New study identifies ganoderic acid DM as potential treatment for breast cancer
Breast cancer is one of the most common cancers in women, with high rates of mortality and morbidity. According to a study published recently in Biotechnology and Applied Biochemistry, Chinese scientists have revealed a new ...
Sep 30, 2024
0
0
Trial supports radiotherapy and cisplatin remaining as the standard of care for p16+ oropharyngeal cancer
The NRG Oncology NRG-HN005 phase II/III clinical trial has not met the non-inferiority criteria to proceed to the phase III portion of the study. The phase II portion of the NRG-HN005 evaluated two experimental treatment ...
18 hours ago
0
0
Clinical trial: Addition of atezolizumab to standard care does not improve limited-stage small cell lung cancer survival
The addition of the cancer immunotherapy drug atezolizumab to the standard of care concurrent chemoradiation (cCRT) did not improve overall survival for patients with limited-stage small cell lung cancer (LS-SCLC) in the ...
18 hours ago
0
0
Improving next-generation cancer treatments with cryoimmunotherapy
Northwestern Medicine scientists have developed a more effective method of delivering a cutting-edge cancer treatment, according to findings published in the journal ACS Nano.
Sep 30, 2024
0
17
AI 'liquid biopsies' using cell-free DNA, protein biomarkers, could aid early detection of ovarian cancer
A blood test that uses artificial intelligence (AI) to detect cancer-related genetic changes and protein biomarkers could help screen women for early signs of ovarian cancer, according to a study by researchers at the Johns ...
Sep 30, 2024
0
16
CAR-T found to be safe and effective on an outpatient basis in community hospitals
In the largest prospective study to date examining the use of chimeric antigen receptor (CAR)-T therapy in a community setting on an outpatient basis, patients with relapsed or refractory large B-cell lymphoma (LBCL) responded ...
Sep 30, 2024
0
21
Trial shows timing matters when adding immunotherapy to chemoradiation for limited-stage small cell lung cancer
People with limited-stage small cell lung cancer may benefit from adding immunotherapy to chemoradiation, but not if both treatments are given at the same time, new research finds. The results suggest that the timing of when ...
Sep 30, 2024
0
0
Spiritual themes, distrust may factor into Black patients' reluctance to participate in cancer clinical trials
Spiritual beliefs and a historically-based distrust of clinical research may factor into Black patients' decisions about whether to participate in cancer trials, according to surveys of patients treated at two Baltimore medical ...
Sep 30, 2024
0
0
Trial: Standard chemoradiation superior to de-intensification approaches for HPV-related oropharyngeal cancer
Researchers looking to de-intensify radiation treatments for people with early-stage, HPV-associated oropharyngeal cancer to prevent long-term side effects halted a large, randomized Phase II/III trial after patients in the ...
Sep 30, 2024
0
0
Post-mastectomy radiation therapy can be shortened by nearly half for patients planning breast reconstruction
An accelerated course of radiation therapy does not increase complications for patients who undergo breast reconstruction following a mastectomy, new research shows. Findings of the large, Phase III RT CHARM trial (Alliance ...
Sep 30, 2024
0
0
Blood cancers: Expert explains what you need to know
Blood cancer is not a diagnosis anyone wants to receive, but understanding the different types of this disease and how best to catch them early is essential, one expert says.
Sep 30, 2024
0
0
IMRT and proton therapy offer equally high quality of life and tumor control for people with prostate cancer
People with low- and intermediate-risk prostate cancer treated with either of two types of contemporary radiation therapy—proton beam therapy or intensity modulated radiation therapy (IMRT)—achieved equally high rates ...
Sep 30, 2024
0
0
Prostate cancer: Family history, genetics and your risk
If you've been diagnosed with prostate cancer, exploring what may have contributed to your cancer might not be at the top of your list. However, learning about your family history and the genetic characteristics of your prostate ...
Sep 30, 2024
0
3
People who experience side effects from cranial radiation therapy may recover full neurocognitive function within months
A substantial number of patients with brain metastases who experience cognitive side effects following radiation therapy may fully regain cognitive function, according to a pooled analysis of three large, Phase III clinical ...
Sep 29, 2024
0
0
